Follow-Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under-Reporting in Oncology Trials?

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1179-1942

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Follow-Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under-Reporting in Oncology Trials? ; volume:43 ; number:3 ; day:13 ; month:12 ; year:2019 ; pages:295-296 ; date:3.2020
Drug safety ; 43, Heft 3 (13.12.2019), 295-296, 3.2020

Creator: Ménard, Timothé
Koneswarakantha, Björn
Rolo, Donato
Barmaz, Yves
Popko, Leszek
Bowling, Rich

Contributor: SpringerLink (Online service)

DOI: 10.1007/s40264-019-00894-3

URN: urn:nbn:de:101:1-2020052223561601529382

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:02 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Ménard, Timothé
Koneswarakantha, Björn
Rolo, Donato
Barmaz, Yves
Popko, Leszek
Bowling, Rich
SpringerLink (Online service)

Other Objects (12)

Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions

Enabling Data-Driven Clinical Quality Assurance: Predicting Adverse Event Reporting in Clinical Trials Using Machine Learning

Adverse Drug Reaction Reporting in Geriatric Oncology in India: An Understudied Topic that Needs Attention

The potential of training specialist oncology nurses in real-life reporting of adverse drug reactions

Radiology reporting in oncology—oncologists’ perspective

The Challenges of Assurance on Non-financial Reporting

Hochschulschrift

Quality assurance of investigator initiated clinical trials in oncology

Reporting oncoimaging in the appropriate oncology setting

Standardizing adverse drug event reporting data

Managing immune-related adverse events in oncology

External assurance and transparency in CSR reporting : European evidence

CEO Compensation and Sustainability Reporting Assurance: Evidence from the UK

Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions

Enabling Data-Driven Clinical Quality Assurance: Predicting Adverse Event Reporting in Clinical Trials Using Machine Learning

Adverse Drug Reaction Reporting in Geriatric Oncology in India: An Understudied Topic that Needs Attention

The potential of training specialist oncology nurses in real-life reporting of adverse drug reactions

Radiology reporting in oncology—oncologists’ perspective

The Challenges of Assurance on Non-financial Reporting

Hochschulschrift

Quality assurance of investigator initiated clinical trials in oncology

Reporting oncoimaging in the appropriate oncology setting

Standardizing adverse drug event reporting data

Managing immune-related adverse events in oncology

External assurance and transparency in CSR reporting : European evidence

CEO Compensation and Sustainability Reporting Assurance: Evidence from the UK

Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions

Enabling Data-Driven Clinical Quality Assurance: Predicting Adverse Event Reporting in Clinical Trials Using Machine Learning

Adverse Drug Reaction Reporting in Geriatric Oncology in India: An Understudied Topic that Needs Attention

The potential of training specialist oncology nurses in real-life reporting of adverse drug reactions

Radiology reporting in oncology—oncologists’ perspective

The Challenges of Assurance on Non-financial Reporting

Hochschulschrift

Quality assurance of investigator initiated clinical trials in oncology

Reporting oncoimaging in the appropriate oncology setting

Standardizing adverse drug event reporting data

Managing immune-related adverse events in oncology

External assurance and transparency in CSR reporting : European evidence

CEO Compensation and Sustainability Reporting Assurance: Evidence from the UK

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Follow-Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under-Reporting in Oncology Trials?

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions

Enabling Data-Driven Clinical Quality Assurance: Predicting Adverse Event Reporting in Clinical Trials Using Machine Learning

Adverse Drug Reaction Reporting in Geriatric Oncology in India: An Understudied Topic that Needs Attention

The potential of training specialist oncology nurses in real-life reporting of adverse drug reactions

Radiology reporting in oncology—oncologists’ perspective

The Challenges of Assurance on Non-financial Reporting

Quality assurance of investigator initiated clinical trials in oncology

Reporting oncoimaging in the appropriate oncology setting

Standardizing adverse drug event reporting data

Managing immune-related adverse events in oncology

External assurance and transparency in CSR reporting : European evidence

CEO Compensation and Sustainability Reporting Assurance: Evidence from the UK

Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions

Enabling Data-Driven Clinical Quality Assurance: Predicting Adverse Event Reporting in Clinical Trials Using Machine Learning

Adverse Drug Reaction Reporting in Geriatric Oncology in India: An Understudied Topic that Needs Attention

The potential of training specialist oncology nurses in real-life reporting of adverse drug reactions

Radiology reporting in oncology—oncologists’ perspective

The Challenges of Assurance on Non-financial Reporting

Quality assurance of investigator initiated clinical trials in oncology

Reporting oncoimaging in the appropriate oncology setting

Standardizing adverse drug event reporting data

Managing immune-related adverse events in oncology

External assurance and transparency in CSR reporting : European evidence

CEO Compensation and Sustainability Reporting Assurance: Evidence from the UK

Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions

Enabling Data-Driven Clinical Quality Assurance: Predicting Adverse Event Reporting in Clinical Trials Using Machine Learning

Adverse Drug Reaction Reporting in Geriatric Oncology in India: An Understudied Topic that Needs Attention

The potential of training specialist oncology nurses in real-life reporting of adverse drug reactions

Radiology reporting in oncology—oncologists’ perspective

The Challenges of Assurance on Non-financial Reporting

Quality assurance of investigator initiated clinical trials in oncology

Reporting oncoimaging in the appropriate oncology setting

Standardizing adverse drug event reporting data

Managing immune-related adverse events in oncology

External assurance and transparency in CSR reporting : European evidence

CEO Compensation and Sustainability Reporting Assurance: Evidence from the UK

Related objects

Reset password